We have used solid-state C-13 NMR to study the structure of the adduct
resulting from the inactivation of the enzyme transglutaminase by 3-h
alo-4,5-dihydroisoxazoles. These inhibitors were conceived on the assu
mption that they would inhibit transglutaminase by attack of an enzyme
active site cysteine thiol on the imine carbon of the dihydroisoxazol
e ring. The tetrahedral intermediate formed could then break down with
the loss of the halide group and the subsequent formation of a stable
imino thioether adduct. We have compared the C-13 CPMAS spectra of th
e chloro-, bromo-, and (ethylthio)dihydroisoxazole inhibitors, and the
results indicate that the chemical shift of the C-3 carbon is sensiti
ve to the nature of the heteroatom. Subtraction of the natural-abundan
ce C-13 solid-state NMR spectrum of the enzyme from that of the enzyme
inactivated by C-3-labeled chlorodihydroisoxazole reveals a broad pea
k at 156 ppm. The chemical shift of this peak is very close to that ob
served for a model 3-ethylthio compound and suggests the formation of
a stable imino thioether enzyme adduct. Similar results were obtained
for lyophilized enzyme adducts and for frozen solutions of the enzyme
adduct in the absence and presence of Ca2+. We have also compared thes
e results with those obtained by solution NMR on an aqueous solution o
f the enzyme-inhibitor complex. The C-13-labeled C-3 resonance was not
observed in this case.